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Objectives: To elucidate the relationship between hospital volume and cardiothoracic surgical 
outcomes in Japan using the annual survey data, obtained between 2005 and 2009, collected by 
the Committee for Scientific Affairs of the Japanese Association for Thoracic Surgery. 
Methods: The relationship between hospital volume and 30-day mortality was analyzed using a 
logistic regression model. The empirical Bayes (EB) method was also used to stabilize any large 
variation resulting from a small sample size. If hospitals whose lower limit of the EB mortality 
95% confidence interval was above the mean EB mortality of all hospitals, they were defined as 
hospitals with “inferior outcomes”. The surgical procedures analyzed were coronary artery 
bypass grafting (CABG: elective + emergency), elective CABG, emergency CABG, 
single-valve surgery, surgery for acute type A dissection, open heart surgery for newborns, open 
heart surgery for infants, surgery for lung cancer, and surgery for esophageal cancer. 
Results: There were large variations in 30-day mortality for all procedures, particularly in the 
lower-volume hospitals. There was a significant but weak inverse correlation between the 
hospital volume and the 30-day mortality rate for elective CABG, emergency CABG, single 
valve surgery, surgery for acute type A dissection, and lung cancer surgery. There was no 
correlation between hospital volume and the 30-day morality for open heart surgery for 
newborns and infants, and esophageal cancer surgery. After EB method adjustment, there was 
no hospital with inferior outcomes for conventional operations such as elective CABG, 
single-valve surgery and lung cancer surgery. The ratio of hospitals with inferior outcomes in 
more complex procedures was 1.8% for open heart surgery for newborns, 0.8% for open heart 
surgery for infants, and 0.2% for esophageal cancer surgery. 
Conclusion: There is a weak or no inverse correlation between the hospital volume and the 
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mortality in cardiothoracic surgery in Japan. Most of the low-volume hospitals are not 
associated with inferior outcomes. The performance of the lower-volume hospitals should be 












4. Most of the reports have shown that a higher hospital volume is associated with better 
outcomes. Accordingly, the Japanese Ministry of Health, Labor, and Welfare decided to reduce 
by 30% the health insurance reimbursement for hospitals that had a cardiac surgery volume of 
less than 100 surgeries per year in 2002; this reduction occurred because US or European 
evidence showed that a lower hospital volume is associated with inferior surgical outcomes . 
However, several Japanese reports indicated that a lower hospital volume was not necessarily 
associated with inferior outcomes 5 6. There were large outcome variations in low-volume 
hospitals, and several lower-volume hospitals showed satisfactory outcomes. Thereafter, the 
regulation was abolished in 2006. 
In 2007, the Committee for Scientific Affairs of the Japanese Association for Thoracic 
Surgery (JATS) reported the relationship between the hospital volume and the 30-day 
cardiothoracic surgery mortality in Japan, based on nationwide data collected between 2000 and 
2004 6. The report indicated that there were inverse correlations between the hospital volume 
and the outcomes, but this report simultaneously raised an issue that there was a wide variety of 
mortality particularly in the lower-volume hospitals. In small-volume hospitals, one death could 
drastically affect the mortality rate, and the data for crude mortality rates could also be 
drastically affected by this scattered data 
7 . In addition, recent improvements in surgical 
techniques, anesthesia, and perioperative care may influence the hospital volume-outcome 
relationship in Japan. Thus, in the present report, we sought to elucidate the latest hospital 
volume-outcome relationship in Japan, and to more accurately adjust the outcome variations, 




PATIENTS AND METHODS 
The JATS Committee for Scientific Affairs conducts an annual cardiothoracic and esophageal 
surgery survey at its Japanese member institutions. The data were collected annually from each 
institution from 2005 to 2009 9 10 11 12 13, as previously described 6. Using the data, we evaluated 
the relationship between the hospital volume and the mortality observed in 10 types of surgeries, 
as previously reported 6. The average response rates from the participating institutions during 
the study period were 96.7% for cardiac surgery, 94.0% for lung surgery, and 91.1% for 
esophageal surgery.  
 
Statistical analysis 
Case volume was determined using the mean number of cases each year for 5 years. Institutions 
providing data for a minimum of 4 years were included in the analysis. Based on the 
relationship between the hospital volume and 30-day mortality, scatter diagrams were prepared. 
The scatter diagram vertical axis represents the 30-day mortality, and the horizontal axis 
represents the average annual hospital volume (average annual institutional case volume). One 
dot represents one institution. The unstratified volume–outcome relationship for all patients with 
a procedure, irrespective of their institutions, was assessed using the Pearson’s correlation 
coefficient method. Risk adjustment was not done. 
The logistic regression model was used to represent the volume categories using the dummy 
variables and to estimate the volume effect. To account for the 5-year longitudinal data, 
generalized estimating equations 14 were used to estimate parameters and standard errors. The 
dummy variables were used in the model to represent the years, and the effects for each year 
were estimated. The odds ratio (OR) was calculated in relation to the volume of the 
highest-volume centers, which was considered to be 1.00. The OR and mortality are cited in the 
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Tables corresponding to each Figure. Statistical significance was conferred only when the lower 
limit of the 95% confidence interval (95% CI) was >1.00, which is marked with an asterisk in 
the corresponding table.  
We calculated the empirical Bayes (EB) and the 95% confidence interval of the predicted 
EB estimates for the hospital mortality rates, as previously described 7 8. The EB estimate is a 
technique used to stabilize the crude estimates close to the estimate for the whole sample. The 
EB-mortality is the mortality adjusted using the EB estimates. The Pearson’s correlation 
coefficient between the hospital volume and the EB-mortality rate was calculated for the total 
acquired heart disease and elective CABG. In addition, we evaluated the hospitals with an 
inferior outcomes corresponding to a high mortality, which are defined as hospitals whose lower 
limit of the EB mortality 95% CI is above the average EB mortality of all the hospitals. This 
means the there is a greater than 95% probability of a negative outcome at the hospital. All P 
values were two-sided, and all analyses were performed with SAS version 9.2 (SAS Institute, 
Cary, NC, USA). 
 
RESULTS 
The total number of patients and corresponding hospitals, and the mean mortality rate of 
patients who underwent each operation between 2000 and 2004 6 and between 2005 and 2009 
are listed in Table 1. A total of 141,181 patients underwent surgery for acquired heart disease 
(CABG, single valve, and acute type A dissection) at 522 hospitals between 2005 and 2009. A 
total of 13,074 patients underwent congenital heart surgery (newborns and infants). A total of 
128,848 patients underwent lung cancer surgery at 647 hospitals, and there were a total of 
24,224 patients who underwent esophageal cancer surgery in 493 hospitals . 
When the 2000 to 2004 and the 2005 to 2009 outcomes are compared, the total number of 
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surgeries for acquired heart disease decreased from 153,616 to 141,181. The reduction was 
because both the number of elective and emergency CABG surgeries decreased between 2005 
and 2009 compared to 2000 to 2004. However, the overall amount of operations increased 
except for that of CABG. The number of surgeries for newborns and infants increased, while the 
number of surgeries at the corresponding hospitals decreased. The mean 30-day mortality was 
reduced in all types of surgery; specifically, the mortality drastically decreased in open heart 
surgery for newborns (from 19.8% to 11.8%) and in esophageal cancer surgery (from 5.80% to 
1.98%). 
 
Surgery for acquired heart disease 
The scatter diagram and the corresponding Table in Figure 1 show the relationship between the 
hospital volume and the 30-day mortality rate in patients who underwent surgery for acquired 
heart disease. A total of 141,181 patients who underwent surgery at 522 institutions had an 
average mortality of 3.40%. Among them, 65 hospitals had more than the average of 100 
surgeries per year, with a corresponding patient mortality of 2.15%; those with fewer than 25 
cases had a higher patient mortality of 4.45% (OR [95% CI]: 1.90 [1.52–2.39]). This means the 
lowest-volume hospitals were associated with 1.90 times higher odds of a negative outcome 
compared with the highest-volume hospitals. Similarly, patients in the 25 to 49 volume group 
and the 50 to 74 volume group had significantly higher mortality compared with the 
highest-volume group. Among the lower-volume hospitals, the patient mortality varied widely; 
however, most of the hospitals’ patient mortality was under 10%. Only a few hospitals had 
extremely high patient mortality. Pearson’s correlation coefficient for the volume–outcome 




Total CABG (elective and emergency) 
A total of 85,600 patients underwent CABG surgery at 518 institutions, and had an average 
mortality of 2.15%. Nineteen hospitals (3.7%) had more than the average of 100 surgeries per 
year with a patient mortality of 1.00%; those with fewer than 25 cases had a higher patient 
mortality of 2.72% (2.52 [1.83-3.48]; Figure 2). The mortality also varied widely among the 
lowest-volume hospitals, but several hospitals in the lowest-volume had 0% patient morality. 
The patients at hospitals with 1 to 24 and 25 to 49 surgeries per year had a higher mortality 
compared with patients at the highest-volume hospitals. Pearson’s correlation coefficient for the 
volume–outcome relationship was −0.168 (p < 0.001). 
 
Elective CABG  
A total of 72,937 patients underwent elective CABG surgery at 518 institutions, and had an 
average mortality of 1.12%. Twelve hospitals (2.3%) had more than the average of 100 surgeries 
per year with a patient mortality of 0.45%; those with less than 25 cases had higher mortality of 
1.35% (2.51 [1.69-3.73]; Figure 3). The patient mortality varied widely among the 
lowest-volume hospitals, but most of the mortality was under 5%. The patients at hospitals with 
a volume of 1 to 24 and 25 to 49 surgeries per year had a higher mortality compared with the 
highest-volume hospitals. Pearson’s correlation coefficient for the volume–outcome relation was 
−0.133 (P < 0.001). 
 
Emergency CABG  
A total of 12,663 patients underwent emergency CABG surgery at 482 institutions, and had an 
average mortality of 8.69%. Seventeen hospitals (3.5%) had more than the average of 20 
surgeries per year, with a patient mortality of 4.51%; those with less than 5 cases had a higher 
9 
 
mortality of 10.50% (2.24 [1.57-3.19]; Figure 4). The mortality varied widely among the 
lowest-volume hospitals (from 0% to 100%). The patients at hospitals with a volume of 1 to 4 
and 5 to 9 surgeries per year had a higher mortality compared with the highest-volume hospitals. 
Pearson’s correlation coefficient for the volume–outcome relationship of the whole group was 
−0.169 (p < 0.001). 
 
Single-valve surgery  
A total of 41,486 patients underwent single-valve surgery at 514 institutions, and had an average 
mortality of 3.21%. Ten hospitals (1.9%) had more than the average of 60 surgeries per year, 
with a patient mortality of 1.60%; those hospitals with less than 15 cases had a higher patient 
mortality (3.80%) compared to those with more surgeries (2.01 [1.45-2.78]; Figure 5). The 
patient mortality varied among the lowest-volume hospitals, but most of the hospitals had a 
patient mortality of less than 10%. The patients at hospitals with a volume of 1 to 14 and 15 to 
29 surgeries per year had a higher mortality compared with the highest-volume hospitals. 
Pearson’s correlation coefficient for the volume–outcome relationship was −0.150 (p < 0.001).  
 
Surgery for acute type A dissection  
A total of 14,095 patients underwent surgery for acute type A dissection at 477 institutions, and 
had an average mortality of 13.41%. Twenty hospitals (4.2%) had more than the average of 20 
surgeries per year, with a patient mortality of 9.7%; hospitals with fewer than 5 surgeries had 
higher patient mortality (16.1%) compared with those with a higher number of cases (1.48 
[1.14-1.93]; Figure 6). The mortality varied widely among the low- and middle-volume 
hospitals (from 0% to 100%). Patients at the lowest volume hospital had a higher mortality 
compared with the highest-volume hospitals. Pearson’s correlation coefficient for the 
10 
 
volume–outcome relationship was −0.176 (p < 0.001). 
 
Open heart surgery for newborns  
A total of 2825 newborn patients underwent open heart surgery at 105 institutions, and had an 
average mortality of 11.80%. Five hospitals (4.8%) had more than the average of 20 surgeries 
per year, with a patient mortality of 6.35%; hospitals with fewer than 5 surgeries had a higher 
mortality of 13.5% (2.46 [1.45-4.17]; Figure 7). The mortality varied widely among the low- 
and middle-volume hospitals (from 0% to 100%). Patients at the lowest volume hospital had a 
higher mortality compared with the highest-volume hospitals. Pearson’s correlation coefficient 
for the volume–outcome relationship was −0.108 (p = 0.273). There was no significant 
correlation between the hospital volume and the mortality in open heart surgery for newborns.  
 
Open heart surgery in infants  
A total of 10,249 infant patients underwent open heart surgery at 115 institutions, and had an 
average mortality of 3.78%. Nine hospitals (7.8%) had more than the average of 50 surgeries 
per year with a patient mortality of 1.36%; those with less than 10 cases had patient mortality of 
5.26% (3.24 [1.53-6.85]; Figure 8). The patients at hospitals with a volume of 1 to 9 and 10 to 
19 surgeries per year had a higher mortality compared with the highest-volume hospitals. 
Pearson’s correlation coefficient for the volume–outcome relationship was −0.151 (p = 0.149). 
There was no significant correlation between the hospital volume and the mortality in open 
heart surgery for infants. 
 
Lung cancer surgery 
A total of 128,848 patients underwent lung cancer surgery at 647 institutions, and had an 
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average mortality of 0.84%. Eighteen hospitals (2.7%) had more than the average of 150 
surgeries per year with a patient mortality of 0.17%; those with less than 10 cases had a higher 
mortality of 2.58% (4.09 [2.39-7.02]; Figure 9). The patients at hospitals with a volume of 1 to 9, 
10 to 24, 25 to 49, and 50 to 74 surgeries per year had a higher mortality compared with patients 
at the highest-volume hospitals. Pearson’s correlation coefficient for the volume–outcome 
relationship was −0.094 (p < 0.016). 
 
Esophageal cancer surgery  
A total of 24,224 patients underwent esophageal cancer surgery at 493 institutions, and had an 
average mortality of 1.98%. Twenty-two hospitals (4.5%) had more than the average of 40 
surgeries per year with a patient mortality of 0.60%; those with less than 5 cases had a mortality 
of 2.41% (3.23 [2.02-5.15]; Figure 10). The patients at hospitals with a volume of 1 to 4, 5 to 9, 
10 to 14, and 15 to 19 surgeries per year had a higher mortality compared with the 
highest-volume hospitals. Pearson’s correlation coefficient for the volume–outcome relationship 
was −0.082 (p = 0.067). There was no significant correlation between the hospital volume and 
the patient mortality in surgery for esophageal cancer surgery. 
 
EB mortality 
Table 2 shows comparison between the crude- and EB- mortality of each procedure regarding 
the hospital volume and mortality relationship over 5 years. For example, the crude mortality of 
the total acquired heart disease of the 5-year average was 3.40 ± 3.80%, and the EB mortality 
was 3.08 ± 1.64%. Pearson’s correlation coefficient for the volume–outcome relationship was 
−0.186 (p = 0.0005) for crude mortality and -0.234 (p <0.0001) for the EB mortality. 
The number of hospitals with “inferior outcomes” evaluated by the EB mortality is shown in 
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Figure 11 and Table 3. The Figure shows the relationship between the hospital volume and the 
EB mortality. The red line shows the average EB mortality for all hospitals over 5 years. If the 
lower bound of the hospital’s EB mortality 95% CI is higher than the average EB mortality, the 
outcome is considered to be “inferior” with a probability of more than 95%. There were 18 
hospitals (3.4%) with inferior outcomes among the lowest volume hospitals (0 to 49) for total 
acquired heart disease; similarly, there were 8 hospitals (1.5%) with inferior outcomes among 
the second-lowest volume hospitals (50 to 99), 1 hospital (0.8%) among the 100 to 199 volume 
hospitals, and 1 hospital (0.8%) with inferior outcomes in the highest volume hospitals. This 
indicates that the proportion of inferior hospitals was low, and that there were some inferior 
hospitals in both the lowest- and highest-volume hospitals. There were no inferior outcomes at 
hospitals for conventional operations such as elective CABG, single-valve surgery, and lung 
cancer surgery, and there were only a few hospitals with inferior outcomes for the more 





In the present report, we reviewed the relationship between the hospital volume and the 
cardiothoracic surgery outcomes in Japan between 2005 and 2009. Compared with our previous 
5-year report (2000-2004) 6, the total number of cardiothoracic surgeries increased except for 
that of CABG. Both elective and emergency CABG surgery numbers decreased possibly 
because of the increasing number of percutaneous coronary interventions particularly with 
drug-eluting stents. The 30-day mortality decreased in all types of surgery, particularly in 
surgery for newborns, infants, and esophageal cancer. Considerable outcome improvements in 
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congenital heart surgery are because of the recently established staged strategies such as 
bilateral pulmonary artery banding for hypoplastic left heart syndrome. The number of lung 
cancer operations is steadily increasing, as is that of hospitals centers for lung cancer operations. 
The lung cancer surgical mortality and morbidity have been stable and are at an acceptable level. 
It should be stressed that the average mortality rate has improved to 1.98% compared with 
5.80% that was previously reported. 
There were significant but low inverse correlations between the hospital volume and the 
30-day mortality in elective CABG, emergency CABG, single-valve surgery, surgery for type A 
dissection, and lung cancer surgery. There was no correlation between hospital volume and the 
30-day patient mortality in open heart surgery for newborns, surgery for infants, and esophageal 
cancer surgery. Although some of the lower-volume hospitals had a high patient mortality, most 
of the low-volume hospitals were associated with low patient mortality.  
In the present report, we used EB estimation to adjust the wide variety of mortality 
particularly in the lower-volume hospitals. There was also a weak but significant inverse 
correlation between the hospital volume and patient outcome, except in surgery for newborns. 
However, there was no hospital with inferior outcomes for conventional operations, such as 
elective CABG, single valve surgery and lung cancer surgery. The ratio of hospital volume to 
patient outcome in inferior hospitals was very low, even in the more complex procedures such 
as open heart surgery for newborns, infants, and esophageal cancer surgery. These findings 
indicate that there is a very weak or no inverse correlation between the hospital volume and 
patient mortality in cardiothoracic surgery in Japan, and that most of the low-volume hospitals 
are not associated with inferior outcomes. The lower-volume hospitals’ performance should be 




Comparison with a foreign database 
The Society for Thoracic Surgery (STS) database published data from 774,881 isolated CABG 
procedures, performed between 2002 and 2006, in adult patients aged 20 to 100 years. The 
overall unadjusted 30-day mortality was 2.3%. The STS executive summary for 10 years 
showed that the unadjusted operative patient mortality for isolated CABG was 2.3% in 2005 and 
2.0% in 2009 16. The annual JATS report showed that the unadjusted 30-day patient mortality 
for total CABG was 2.0% in 2005 9 and 1.6% in 2009 13. 
The STS database also published data from 109,759 adult isolated valve surgeries (without 
concomitant CABG), that were performed between 2002 and 2006 17. There were 67,292 cases 
of isolated aortic valve replacement (AVR), 21,229 cases of isolated mitral valve replacement 
(MVR), or 21,238 isolated mitral valve repair (MVRpair). The overall unadjusted 30-day 
mortality was 3.4%. The unadjusted 30-day patient mortalities for each procedure were 3.2% for 
AVR, 5.7% for MVR, and 1.6% for MVRpair. The STS executive summary for 10 years showed 
that the unadjusted operative mortalities in 2005 were 2.9% for isolated AVR, 5.0% for 
AVR+CABG, 5.2% for isolated MVR, 11.4% for MVR+CABG, 1.4% for isolated MVRpair, 
and 7.0% for MVRpair+CABG; the unadjusted operative mortalities in 2009 were 3.0% for 
isolated AVR, 4.7% for AVR+CABG, 5.2% for isolated MVR, 9.7% for MVR+CABG, 1.3% for 
isolated MVRpair, and 5.5% for MVRpair+CABG. The Japanese annual report, however, 
included isolated valve surgery with or without concomitant CABG 9 13. The unadjusted 30-day 
mortality in 2005 was 2.1% for AVR, 3.2% for MVR, and 1.6% for MVRpair, and in 2009, it 
was 2.5% for AVR, 3.8% for MVR, and 1.4% for MVRpair. The valve surgery outcomes did not 
improve both in the US and Japan, which may be due to the expanding surgical indication and 
the increasing number of high-risk patients. 
The STS executive summary reported the congenital heart surgery data summary from 2007 
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16. Between 2007 and 2010, a total of 14,971 newborns underwent congenital heart surgery and 
the unadjusted in-hospital mortality was 10.1%. Similarly, a total of 25,323 infants underwent 
congenital heart surgery and the unadjusted in-hospital mortality was 2.9%. In Japan, a total of 
2342 newborns underwent congenital heart surgery between 2006 and 2009 10 11 12 13, and the 
unadjusted in-hospital mortality was 12.6%. A total of 8482 infants underwent congenital heart 
surgery during the same period and the in-hospital mortality was 3.7%.  
Thirty-day mortalities for lung cancer surgeries in Japan were 0.8% in 1997 and 0.4% in 2006, 
and 2.3% in 2008 in the US. In esophageal cancer surgery, 30-day mortalities in Japan were 
1.2% in 2007 and 1.2% in 2008, and in-hospital mortalities were 3.4% in 2007 and 2.8% in 
2008 11 12 , which was better than the in-hospital mortality (8.9%) in the US between 2007 and 
2008 18. 
 
More complex vs. less complex procedures 
A number of studies have shown the inverse correlation between the hospital volume and 
patient mortality 19 18 20. However, the strength of the correlation is different between more 
complex and less complex procedures 20 21 4 22. CABG is a less complex procedure and is 
performed more frequently than any other more complex procedures. Compared with other 
complex, but less frequently performed, procedures, most of the studies reported a weak or no 
hospital volume-mortality relationship for CABG surgery. However, there were significant 
hospital volume-mortality relationship in more complex procedures such as aortic root 
replacement 19, mitral valve surgery 23, and pancreatectomy 4 
In the present study, however, there was a very low or no correlation between the hospital 
volume and outcome in all types of procedures. After adjustment using the EB-method, there 
was no inferior hospital outcome regarding conventional procedures such as elective CABG, 
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single-valve surgery. Even in more complex procedures such as surgery for newborns, there 
were only a few hospitals with inferior outcomes. These outcomes indicate that lower-volume 
hospitals are not necessarily associated with high mortality regardless of the complexity of 
procedures in Japan. For congenital heart surgery, however, there was no correlation between 
hospital volume and outcome both for newborns and infants, which may be due to relatively 
wide variety of mortality not only in lower-volume but also higher-volume hospitals. In addition, 
the small sample size for congenital heart surgery may influence the outcomes. 
 
Low-volume hospitals: are they really inferior? 
The lower-volume hospitals had significantly higher mortality rates as reported by several 
studies. However, there was a wide residual variability in the outcomes at all hospital volumes. 
Because of this variation, volume alone may be a poor predictor of an individual hospital’s true 
risk-adjusted mortality rate 20. There have been important issues to be addressed regarding the 
outcomes of lower-volume hospitals. Particularly in Japan, where more lower-volume hospitals 
exist compared with the US or Europe, the issue should be carefully scrutinized. First, the 
number of operations in “high-volume” hospitals in Japan was different from that of the US. For 
example, recent report from the STS database defined hospitals with more than 450 CABGs per 
year as the highest-volume and those less than 100 as the lowest-volume hospitals 20. In the 
present report, if the US definition is applied, most of the Japanese hospitals are classified into 
the lowest-volume hospitals. As shown above, however, CABG outcomes were similar or 
somewhat better in Japan than in the US. Although cardiovascular surgery programs are 
different between the US and Japan, the lower-volume hospital performance should be carefully 
scrutinized. In addition, CABG volumes have decreased both in the US and Japan because of 
better medical therapy and the increasing use of percutaneous coronary intervention. However, 
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overall CABG mortality has continued to decrease despite progressively lower volumes and 
increasing patient severity. This might reflect both the relatively weaker volume–outcome 
association for CABG compared with other procedures and improvements in surgical 
techniques, anesthesia, and perioperative care. 
In the present study, we used the EB method to adjust the variability of low-volume hospitals. 
Although an inverse correlation between hospital volume and patient mortality existed, there 
was no or only a few hospitals with inferior outcomes. Furthermore, there were some hospitals 
with inferior outcomes in the lowest-volume and also in the moderate-volume hospitals in total 
acquired heart disease. To evaluate the hospital-volume-outcome relationships more accurately, 
risk adjustment according to the patients’ preoperative risk factors, such as with propensity 
matching, may be essential 24. 
 
CONCLUSIONS 
There is weak or no inverse correlation between the hospital volume and the 30-day mortality in 
cardiothoracic surgery in Japan. Most of the low-volume hospitals were not associated with 
inferior outcomes. The performance of the lower-volume hospitals should be carefully 
scrutinized using risk adjustment. 
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Scatter diagram for each procedure showing the 30-day mortality rate according to the number 
of operations. The corresponding table shows the actual number of operations and the mortality 
rates.  
r: Pearson’s correlation coefficient 
SD: standard deviation 
CV: coefficient of variance 
LCL: lower confidence limit 
UCL: upper confidence limit;  
*statistically significant 
 
Figure 11  
The relationship between the hospital volume and EB mortality. The red line shows the 
5-year average EB mortality of all hospitals. If the lower limit of the EB mortality 95% 
confidence interval for each hospital is higher than the average EB mortality, the outcome is 
considered to have a greater than 95% chance of being inferior. 
Blue circles: Hospitals with outcomes of non-inferiority 
Red squares: Hospitals with outcomes of inferiority 
Black bars: Lower 95% confidence interval 
Upper panel: number of hospitals with inferior outcomes in each stratification (1-49, 50-99, 
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  Mortality (%) Odds 95% 95% r 
Hospitals Patients Mean S.D. C.V. ratio LCL UCL p-value 
1: 1-24 125  8398  4.45  6.62  148.7  1.90 * 1.52  2.39  -0.186  
2: 25-49 187  33885  3.61  2.52  69.7  1.76*  1.48  2.09  p<0.001 
3: 50-74 101  30778  3.00  2.07  69.0  1.46*  1.20  1.78    
4: 75-99 44  18566  2.26  1.40  61.8  1.09  0.86  1.38    
5: 100- 65  49554  2.15  1.14  53.1  1.00  - -   
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Figure 1 










  Mortality (%) Odds 95% 95% r 
Hospitals Patients Mean S.D. C.V. ratio LCL UCL p-value 
1: 1-24 245  16622  2.72  4.21  154.9  2.52 * 1.83  3.48  -0.168  
2: 25-49 183  31583  1.83  1.57  85.8  1.81 * 1.31  2.49  p<0.001 
3: 50-74 53  16004  1.28  0.84  65.7  1.28  0.91  1.80    
4: 75-99 18  7954  1.48  1.10  74.1  1.47  0.94  2.32    
5: 100- 19  13437  1.00  0.81  81.1  1.00  - -   
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Total CABG (elective + Emergency)Figure 2 










  Mortality (%) Odds 95% 95% r 
Hospitals Patients Mean S.D. C.V. ratio LCL UCL p-value 
1: 1-24 294  19579  1.35  2.65  195.6  2.51 * 1.69  3.73  -0.133  
2: 25-49 155  26142  0.91  1.02  112.6  1.80 * 1.20  2.69  p=0.002 
3: 50-74 42  12505  0.69  0.57  83.2  1.43  0.92  2.23    
4: 75-99 15  6301  0.66  0.67  102.1  1.33  0.71  2.50    
5: 100- 12  8410  0.45  0.31  69.8  1.00  - -   
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  Mortality (%) Odds 95% 95% r 
Hospitals Patients Mean S.D. C.V. ratio LCL UCL p-value 
1: 1-4 293  3123  10.50  15.94  151.9  2.24 * 1.57  3.19  -0.169  
2: 5-9 124  4184  6.59  5.43  82.4  1.50 * 1.05  2.14  p<0.001 
3: 10-14 40  2381  4.74  4.29  90.5  1.09  0.71  1.68    
4:15-19 8  673  3.76  1.61  42.9  0.79  0.51  1.22    
5: 20- 17  2302  4.51  3.05  67.7  1.00  - -   
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  Mortality (%) Odds 95% 95% r 
Hospitals Patients Mean S.D. C.V. ratio LCL UCL p-value 
1: 1-14 310  11958  3.80  7.12  187.4  2.01 * 1.45  2.78  -0.150  
2: 15-29 133  13451  2.65  2.16  81.3  1.56 * 1.12  2.18  p<0.001 
3: 30-44 44  7792  1.77  1.12  63.4  1.08  0.76  1.54    
4: 45-59 17  4217  1.61  1.12  69.7  0.97  0.63  1.50    
5: 60- 10  4068  1.60  0.80  49.9  1.00  - -   
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  Mortality (%) Odds 95% 95% r 
Hospitals Patients Mean S.D. C.V. ratio LCL UCL p-value 
1: 1-4 266  3051  16.07  19.28  120.0  1.48 * 1.14  1.93  -0.176  
2: 5-9 140  4891  10.62  7.99  75.2  1.13  0.86  1.48  p<0.001 
3: 10-14 36  2129  9.01  5.38  59.8  0.97  0.70  1.32    
4: 15-19 15  1245  7.86  4.29  54.6  0.84  0.58  1.22    
5: 20- 20  2779  9.70  5.04  51.9  1.00  - -   
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  Mortality (%) Odds 95% 95% r 
Hospitals Patients Mean S.D. C.V. ratio LCL UCL p-value 
1: 1-4 65  618  13.52  16.80  124.3  2.46 * 1.45  4.17  -0.108  
2: 5-9 27  948  9.04  10.01  110.7  1.42  0.73  2.76  p=0.273 
3: 10-19 8  487  10.53  6.99  66.4  1.68  0.85  3.31    
4: 20- 5  772  6.35  3.71  58.4  1.00  - -   
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  Mortality (%) Odds 95% 95% r 
Hospitals Patients Mean S.D. C.V. ratio LCL UCL p-value 
1: 1-9 33  294  5.26  12.64  240.2  3.24 * 1.53  6.85  -0.151  
2: 10-19 45  2654  3.75  3.32  88.5  2.67 * 1.69  4.22  p=0.108 
3: 20-49 28  3850  2.84  2.29  80.6  1.95 * 1.22  3.13    
4: 50- 9  3451  1.36  0.80  58.8  1.00  - -   
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Open heart surgery for the infantsFigure 8 










  Mortality (%) Odds 95% 95% r 
Hospitals Patients Mean S.D. C.V. ratio LCL UCL p-value 
1: 1-9 109  2555  2.58  9.64  374.1  4.09 * 2.39  7.02  -0.094  
2: 10-24 178  14023  0.53  0.93  177.5  1.79 * 1.24  2.60  p=0.016 
3: 25-49 175  30711  0.53  0.69  128.9  1.85 * 1.33  2.56    
4: 50-74 90  26448  0.42  0.42  100.7  1.49 * 1.07  2.09    
5: 75-99 47  19580  0.40  0.34  86.6  1.38  0.96  2.00    
6: 100-149 30  17372  0.43  0.40  94.1  1.52  1.00  2.30    
7: 150- 18  18159  0.29  0.17  58.2  1.00  - -   
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  Mortality (%) Odds 95% 95% r 
Hospitals Patients Mean S.D. C.V. ratio LCL UCL p-value 
1: 1-4 263  3116  2.41  8.12  336.8  3.23 * 2.02  5.15  -0.082  
2: 5-9 95  3131  2.03  2.66  131.0  3.59 * 2.28  5.65  p=0.067 
3: 10-14 45  2648  1.30  1.66  127.2  2.31 * 1.37  3.90    
4: 15-19 25  2071  1.56  2.38  152.5  2.82 * 1.37  5.81    
5: 20-29 24  2914  1.01  1.12  111.9  1.65  0.91  3.00    
6: 30-39 19  3215  0.79  0.73  92.9  1.33  0.77  2.29    
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Esophageal cancer surgeryFigure 10 
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Average hospital volume (per year) 
Figure 11 
Average EB mortality  
of all hospitals 
Table 1. Number of patients, hospitals, and mean 30-day mortality (2005 -2009 vs. 2000 -2004) 
                
2005-2009 2000-2004** 
Procedures Patients Hospitals Mean 30-day  mortality (%)   Patients Hospitals 
Mean 30-day  
mortality (%) 
Surgery for acquired heart disease* 141181 522 3.40 153616 556 3.90 
   Elective + emergency CABG 85600 518 2.15 101321 551 2.80 
     Elective CABG 72937 518 1.12 84468 483 1.50 
     Emergency CABG 12663 482 8.69 13900 509 10.90 
   Single-valve surgery 41486 514 3.21 40619 485 3.70 
   Surgery for acute type A dissection 14095 477 13.41 10097 439 16.30 
Open heart surgery for newbones 2825 105 11.80 2611 131 19.80 
Open heart surgery for infants 10249 115 3.78 8586 135 5.90 
Lung cancer surgery 128848 647 0.84 94854 526 0.97 
Esophageal cancer surgery 24224 493 1.98   21020 551 5.80 
*CABG + single valve surgery + Acute type A dissection surgery 
**reference #6 
Table 2. Hospital volume and mortality: Crude vs. EB mortality for 5 years 
                    
  Number of hospitals Number of operations   30-day mortality* (mean ± SD, %) 
Variation  
coefficient 
Pearson's correlation coefficient for 
hospital volume and mortality* p value 
Acquired heart disaese 522 141181 Crude 3.40  ± 3.80  111.8  -0.186  0.0005 
EB 3.08  ± 1.64  53.4  -0.234  <.0001 
   Elective + emergency CABG 518 85600 Crude 2.15  ± 3.11  144.8  -0.168  0.0001 
EB 1.80  ± 1.00  55.5  -0.208  <.0001 
     Elective CABG 518 72937 Crude 1.12  ± 2.10  186.4  -0.133  0.0024 
EB 0.87  ± 0.47  54.7  -0.148  0.0008 
     Emergency CABG 482 12663 Crude 8.69  ± 13.01  149.6  -0.169  0.0002 
EB 6.63  ± 3.08  46.4  -0.195  <.0001 
   Single-valve surgery 514 41486 Crude 3.21  ± 5.70  177.4  -0.150  0.0007 
EB 2.50  ± 0.93  37.3  -0.212  <.0001 
   Surgery for acute type A dissection 477 14095 Crude 13.41  ± 15.45  115.2  -0.176  0.0001 
EB 10.81  ± 3.94  36.5  -0.143  0.0017 
Open heart surgery for newborns 105 2825 Crude 11.80  ± 14.42  122.2  -0.108  0.2731 
EB 10.68  ± 5.30  49.6  -0.168  0.0871 
Open heart surgery for infants 115 10249 Crude 3.78  ± 7.19  190.4  -0.151  0.1078 
EB 2.78  ± 1.22  43.8  -0.259  0.0052 
Surgery for lung cancer 647 128848 Crude 0.84  ± 4.07  485.5  -0.094  0.0163 
EB 0.42  ± 0.19  44.2  -0.077  0.0507 
Surgery for esophageal cancer 493 24224 Crude 1.98  ± 6.12  308.7  -0.082  0.0673 
      EB 1.18  ± 0.86  73.4  -0.098  0.0302 
* 5-year average 
Table 3. Number of hospitals with "inferior" outcomes assessed by EB mortality 
Type of surgery Hospital volume* No. of hospitals Number of hospitals  with "inferior “ outcomes 
Total acquired heart disease 0-49 312 18 (3.4%) 
50-99 145 8 (1.5%) 
100-199 53 1 (0.2%) 
  200- 12 1 (0.2%) 
Elective + emergency CABG 0-24 245 2 (0.4%) 
25-49 183 2 (0.4%) 
50-99 71 1 (0.2%) 
  100- 19 0  
Elective CABG 0-24 294 0 
25-49 155 0 
50-99 57 0 
  100- 12 0 
Emergency  CABG 0-9 417 0 
10-19 48 0 
20-29 10 0 
  30- 7 0 
Single valve surgery 0-19 377 0 
20-39 105 0 
40-59 22 0 
  60- 10 0 
Surgery for acute type A dissection 0-9 406 3 (0.6%) 
10-19 51 0 
20-29 16 1 (0.2%) 
  30- 4 0 
Open heart surgery for newborns 0-9 96 2 (1.8%) 
10-19 8 0 
20-29 2 0 
  30- 3 0 
Open heart surgery for infants 0-19 78 0 
20-39 27 1 (0.8%) 
40-59 4 0 
  60- 6 0 
Surgery for lung cancer 0-49 462 0 
50-99 137 0 
100-199 41 0 
  200- 7 0 
Surgery for esophageal cancer 0-19 428 1 (0.2%) 
20-39 43 0 
40-59 12 0 
  60- 10 0 
* Mean number of surgery per year  
** Reference is mean EB mortaloty for 5-year average 
